Market Cap 12.45B
Revenue (ttm) 0.00
Net Income (ttm) -600.09M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.16
Volume 3,958,400
Avg Vol 2,329,758
Day's Range N/A - N/A
Shares Out 193.32M
Stochastic %K 89%
Beta 1.25
Analysts Strong Sell
Price Target $79.90

Company Profile

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 481 6801
Address:
700 Saginaw Drive, Redwood City, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:17 AM
$RVMD is currently trading at $67.75, with an RSI of 81.94, indicating it is overbought and may face downward pressure. The 30-day moving average (MA30) is at 55.7, and the 50-day moving average (MA50) is at 51.19, suggesting strong bullish momentum in the short to medium term. However, the high of $69.02 from the last 60 days indicates a potential resistance level, while the low of $35.62 provides a clear support baseline. Given the current overbought condition and proximity to the 60-day high, a cautious approach is warranted. Suggested entry could be around $66.00, with a stop loss at $64.30 (just below the recent support). Target 1 is set at $69.00, aligning with the recent high, and Target 2 at $70.50, providing a buffer for potential breakout. Monitor for any signs of reversal or increased volatility due to the high RSI. https://privateprofiteers.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 14 at 9:19 PM
💎 LiquidTheta® Live Actionable Trade Asset: $RVMD Contracts: $RVMD January 15, 2027 $65 Calls Scale in: $13.91- $17.00 Scale out: $54.09-$92.73 Profit Potential : 392% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:20 PM
Hedge Alert Live - Protect Your Portfolio Contract: $RVMD $60.00 Put · NOV 21, 2025 Exp Entry Price: $0.60 - $0.90 Exit Price Target: $1.23 Profit Margin: +105% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
EventHorizon2021
EventHorizon2021 Nov. 14 at 4:20 PM
$RVMD Been waiting for this moment…my middle schooler has rotted my brain
1 · Reply
RunnerSignals
RunnerSignals Nov. 14 at 3:56 PM
breakout buzz $CDTX $RVMD $APGE $OWLT $CELC all tapping fresh 52-week highs. biotech acting like it found an extra gear today. what’s driving the surge? full breakdown inside. https://stocksrunner.com/news/2025-11-14-52-week-high-breakout-stocks-to-watch-right-now
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 7:39 AM
Hedge Alert Live - Protect Your Portfolio Contract: $RVMD $60.00 Put · NOV 21, 2025 Exp Entry Price: $0.60 - $1.20 Exit Price Target: $1.07 Profit Margin: +78% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:50 AM
$RVMD is currently experiencing strong bullish momentum, closing at $64.38 with an RSI of 82.1, indicating it is overbought. The price is above the 30-day moving average (MA30) of 55.0 and the 50-day moving average (MA50) of 50.64, reinforcing a bullish trend. The recent high of $66.11 suggests resistance, while the low of $35.42 indicates significant support. Given the overbought condition, a pullback may occur. Suggested entry is around $63.00 to capitalize on a potential retracement. Set a stop loss at $61.50 to manage risk. For targets, aim for $66.00, aligning with the 60D high, and consider a secondary target at $68.00 if momentum continues. Monitor the RSI for signs of reversal and adjust the strategy accordingly. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:57 AM
$RVMD is currently trading at $64.08, near its 60-day high of $64.26, indicating strong bullish momentum. The RSI at 90.45 suggests that the stock is overbought, which could lead to a potential pullback. The short-term moving averages (MA30 at 53.71 and MA50 at 49.61) are significantly below the current price, reinforcing the bullish trend but also highlighting the risk of a correction. Given this context, a cautious approach is warranted. Suggested entry could be around $63.50, allowing for a slight pullback. A stop loss should be placed at $61.50 to manage risk effectively. For targets, consider $66.00 as the first target, aligning with the bullish sentiment, and $68.00 as a secondary target if momentum continues. Monitor the RSI closely; if it begins to decline significantly, reassess the position. https://privateprofiteers.com
0 · Reply
RisingTrendQ
RisingTrendQ Nov. 12 at 8:16 PM
$RVMD Stealth funds stacking low, NXXT climbing
0 · Reply
RunnerSignals
RunnerSignals Nov. 12 at 7:44 PM
52-Week High Club! $LLY $BAC $GM $TSEM $RVMD all breaking fresh highs like it’s earnings season deja vu 😎 https://stocksrunner.com/news/2025-11-12-52-week-high-breakouts-in-top-momentum-stocks
0 · Reply
Latest News on RVMD
Revolution Medicines: Risky Buy On Recent Share Price Dip

Dec 4, 2024, 9:09 AM EST - 1 year ago

Revolution Medicines: Risky Buy On Recent Share Price Dip


PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:17 AM
$RVMD is currently trading at $67.75, with an RSI of 81.94, indicating it is overbought and may face downward pressure. The 30-day moving average (MA30) is at 55.7, and the 50-day moving average (MA50) is at 51.19, suggesting strong bullish momentum in the short to medium term. However, the high of $69.02 from the last 60 days indicates a potential resistance level, while the low of $35.62 provides a clear support baseline. Given the current overbought condition and proximity to the 60-day high, a cautious approach is warranted. Suggested entry could be around $66.00, with a stop loss at $64.30 (just below the recent support). Target 1 is set at $69.00, aligning with the recent high, and Target 2 at $70.50, providing a buffer for potential breakout. Monitor for any signs of reversal or increased volatility due to the high RSI. https://privateprofiteers.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 14 at 9:19 PM
💎 LiquidTheta® Live Actionable Trade Asset: $RVMD Contracts: $RVMD January 15, 2027 $65 Calls Scale in: $13.91- $17.00 Scale out: $54.09-$92.73 Profit Potential : 392% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:20 PM
Hedge Alert Live - Protect Your Portfolio Contract: $RVMD $60.00 Put · NOV 21, 2025 Exp Entry Price: $0.60 - $0.90 Exit Price Target: $1.23 Profit Margin: +105% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
EventHorizon2021
EventHorizon2021 Nov. 14 at 4:20 PM
$RVMD Been waiting for this moment…my middle schooler has rotted my brain
1 · Reply
RunnerSignals
RunnerSignals Nov. 14 at 3:56 PM
breakout buzz $CDTX $RVMD $APGE $OWLT $CELC all tapping fresh 52-week highs. biotech acting like it found an extra gear today. what’s driving the surge? full breakdown inside. https://stocksrunner.com/news/2025-11-14-52-week-high-breakout-stocks-to-watch-right-now
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 7:39 AM
Hedge Alert Live - Protect Your Portfolio Contract: $RVMD $60.00 Put · NOV 21, 2025 Exp Entry Price: $0.60 - $1.20 Exit Price Target: $1.07 Profit Margin: +78% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:50 AM
$RVMD is currently experiencing strong bullish momentum, closing at $64.38 with an RSI of 82.1, indicating it is overbought. The price is above the 30-day moving average (MA30) of 55.0 and the 50-day moving average (MA50) of 50.64, reinforcing a bullish trend. The recent high of $66.11 suggests resistance, while the low of $35.42 indicates significant support. Given the overbought condition, a pullback may occur. Suggested entry is around $63.00 to capitalize on a potential retracement. Set a stop loss at $61.50 to manage risk. For targets, aim for $66.00, aligning with the 60D high, and consider a secondary target at $68.00 if momentum continues. Monitor the RSI for signs of reversal and adjust the strategy accordingly. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:57 AM
$RVMD is currently trading at $64.08, near its 60-day high of $64.26, indicating strong bullish momentum. The RSI at 90.45 suggests that the stock is overbought, which could lead to a potential pullback. The short-term moving averages (MA30 at 53.71 and MA50 at 49.61) are significantly below the current price, reinforcing the bullish trend but also highlighting the risk of a correction. Given this context, a cautious approach is warranted. Suggested entry could be around $63.50, allowing for a slight pullback. A stop loss should be placed at $61.50 to manage risk effectively. For targets, consider $66.00 as the first target, aligning with the bullish sentiment, and $68.00 as a secondary target if momentum continues. Monitor the RSI closely; if it begins to decline significantly, reassess the position. https://privateprofiteers.com
0 · Reply
RisingTrendQ
RisingTrendQ Nov. 12 at 8:16 PM
$RVMD Stealth funds stacking low, NXXT climbing
0 · Reply
RunnerSignals
RunnerSignals Nov. 12 at 7:44 PM
52-Week High Club! $LLY $BAC $GM $TSEM $RVMD all breaking fresh highs like it’s earnings season deja vu 😎 https://stocksrunner.com/news/2025-11-12-52-week-high-breakouts-in-top-momentum-stocks
0 · Reply
Irish_lass
Irish_lass Nov. 12 at 7:06 PM
$RVMD Are we having fun yet?
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 12 at 4:35 PM
💎 LiquidTheta® Live Actionable Trade Asset: $RVMD Contracts: $RVMD January 15, 2027 $65 Calls Scale in: $13.68- $16.73 Scale out: $53.22-$91.23 Profit Potential : 239% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
lily_mitchell19
lily_mitchell19 Nov. 12 at 11:54 AM
$RVMD oncology m
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:33 AM
$RVMD is currently trading at $64.08, near its 60-day high of $64.26, indicating strong bullish momentum. The RSI at 90.45 suggests that the stock is overbought, which could lead to a potential pullback. The short-term moving averages (MA30 at 53.71 and MA50 at 49.61) are significantly below the current price, reinforcing the bullish trend but also highlighting the risk of a correction. Given this context, a cautious approach is warranted. Suggested entry could be around $63.50, allowing for a slight pullback. A stop loss should be placed at $61.50 to manage risk effectively. For targets, consider $66.00 as the first target, aligning with the bullish sentiment, and $68.00 as a secondary target if momentum continues. Monitor the RSI closely; if it begins to decline significantly, reassess the position. https://privateprofiteers.com
0 · Reply
RonIsWrong
RonIsWrong Nov. 12 at 1:25 AM
$RVMD these worked out. Sold most for 100 percent gain.
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 11 at 8:20 PM
💎 LiquidTheta® Live Actionable Trade Asset: $RVMD Contracts: $RVMD January 15, 2027 $65 Calls Scale in: $13.23- $16.18 Scale out: $51.47-$88.23 Profit Potential : 377% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
Iightning
Iightning Nov. 11 at 3:20 PM
1ightning® Options Trade Alert (Actionable) | Buy $RVMD Nov 21 $65 Call | Enter: $1.33 Exit: $2.15 | Profit: 62.48% ROI | https://1ightning.com
0 · Reply
StellaJean
StellaJean Nov. 11 at 1:10 PM
$RVMD 19 million shares short and one of the most obvious cup and handle situations.
2 · Reply
StellaJean
StellaJean Nov. 10 at 7:35 PM
$RVMD Investor’s conference tomorrow. 19 million shares short. Seems excessive?
1 · Reply
Irish_lass
Irish_lass Nov. 10 at 6:57 PM
$RVMD 🏁 $RVMD I concur. Outperform/$77 “RBC Capital said in its initiation report: We believe RVMD is best positioned to execute on targeting RAS across oncology, given their impressive efficacy data, development lead, and focused pipeline. We think with a ph.Ill readout in 2026 highly likely to hit, a regulatory path significantly derisked by the recent CNPV, and a commercial opportunity of >$7B based on our checks with upwards of 50% intent to prescribe, we think shares are undervaluing the enthusiasm for daraxonrasib. While a certain amount of success is already priced in, and 1st gen KRAS inhibitor launches have been slow, we think RVMD's approach is likely to succeed and differentiate, and we would be buyers.”
0 · Reply
victorgn
victorgn Nov. 10 at 6:10 PM
$RVMD tgt : 80.95 $
0 · Reply
victorgn
victorgn Nov. 10 at 6:10 PM
$RVMD 63 $ back to it now
0 · Reply